5 Results for "

Ser7

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "Ser7" in MCE Product Catalog:

製品番号: HY-P5526
Target:  

Casein Kinase

研究分野:  

Others

CCK1-specific peptide substrate is a biological active peptide. (This peptide sequence is based on rabbit muscle glycogen synthase with Ser7 phosphorylated. It is a peptide substrate for Casein Kinase I (CK1). CK1 phosphorylates Ser10. Ser7 is phosphorylated by PKA in vivo.)
loading...
    loading...
製品番号: HY-P1933
Target:  

阻害性抗体

研究分野:  

Cancer

[pSer2, pSer5, pSer7]-CTD, a substrate for CDK7 (cyclin dependent protein kinase), is a phosphorylated polypeptide at ser2, ser5 and ser7 sites of RNA polymerase II carboxy-terminal domain (CTD) .
loading...
    loading...
製品番号: HY-P1933A
Target:  

CDK

研究分野:  

Cancer

[pSer2, pSer5, pSer7]-CTD (TFA), a substrate for CDK7 (cyclin dependent protein kinase), is a phosphorylated polypeptide at ser2, ser5 and ser7 sites of RNA polymerase II carboxy-terminal domain (CTD) .
loading...
    loading...
製品番号: HY-P5526A
Target:  

Casein Kinase

研究分野:  

Others

CCK1-specific peptide substrate acetate is a biological active peptide. (This peptide sequence is based on rabbit muscle glycogen synthase with Ser7 phosphorylated. It is a peptide substrate for Casein Kinase I (CK1). CK1 phosphorylates Ser10. Ser7 is phosphorylated by PKA in vivo.)
loading...
    loading...
製品番号: HY-189062
Target:  

CDK Apoptosis

研究分野:  

Cancer

ZJC-11 is a CDK7 inhibitor with an IC50 of 5.4 nM. ZJC-11 binds covalently to CDK7, inhibits CDK7-dependent phosphorylation of RNAPII at Ser2, Ser5 and Ser7 sites, and suppresses transcriptional processes. ZJC-11 acts as a cell cycle inhibitor, inhibits the G2/M checkpoint pathway, and induces G2/M phase arrest. ZJC-11 induces DNA damage-driven cellular senescence and cell death. ZJC-11 exhibits antiproliferative activity against triple-negative breast cancer both in vitro and in vivo. ZJC-11 can be used for research related to triple-negative breast cancer
loading...
    loading...